A clear difference in HFCWO devices

Since therapies can be effective only when patients comply with them, the SmartVest® Airway Clearance System stands apart among high frequency chest wall oscillation (HFCWO) devices. Electromed, Inc., designed the SmartVest System for maximum ergonomic comfort and lifestyle convenience, so patients can readily and consistently fit HFCWO therapy into their daily routines.

HFCWO has been proven to be an effective therapy for a wide range of conditions. And when patients use the simple, comfortable SmartVest HFCWO system as intended, the changes can be life-transforming, as seen in the stories told by patients and clinicians.

SmartVest vests

Engineered for therapy adherence

All HFCWO systems are not created equal. Every SmartVest System has an array of features that make it easier to use and enable greater freedom and quality of life, meaning patients are more likely to adhere to their treatment:

SmartVest System engineering

Three systems. One clear difference.

SmartVest SQL systemSmartVest 2100 systemSmartVest inpatient therapy

A win for patients, clinicians and health plans

A patient-first approach to HFCWO device design and customer care makes the proven, effective SmartVest System a win-win-win in the fight against impaired airway clearance:

  • Patients and caregivers win by gaining maximum benefit from HFCWO therapy while experiencing minimal lifestyle inconvenience. Quietly, quickly delivering consistently effective therapy in a variety of positions and locations, the SmartVest System helps clear the airways of excess mucus, so patients can return to activities they enjoy and the quality of life they desire.
  • Clinicians win with better outcomes. Whether they prescribe the SmartVest System for inpatient or in-home use, patients consistently tolerate and adhere to their HFCWO therapy, helping mitigate the mucus retention that can cause inflammation, recurring lung infections and permanent lung damage.
  • Health plans win with lower total costs, since patients’ consistent therapy adherence to HFCWO helps reduce the incidence of hospitalizations, readmissions and complications.